Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy~* Postmenopausal~* Hysterectomized or non-hysterectomized~* Moderate or severe vaginal dryness and soreness~* Successful completion of the study VAG/PD/009/USA~Exclusion Criteria:~* Known, suspected, or past history of breast cancer~* Known, suspected, or past history of hormone-dependent tumor~* Genital bleeding of unknown etiology~* Acute thrombophlebitis or thromboembolic disorders or a past history of these conditions, associated with previous estrogen use~* Subjects who had adverse events during the final visit, or discontinued prematurely, or were noncompliant in VAG/PD/009/USA~* Exposure to any investigational new drug (other than what was dispensed in VAG/PD/009/USA) within the previous 30 days

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).